D Marshall

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation
    Elisabeth Fenwick
    Public Health and Health Policy, University of Glasgow, Glasgow, UK
    BMC Health Serv Res 6:52. 2006
  2. ncbi Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort
    D Marshall
    Bayer Diagnostics, Emeryville, CA, USA
    Lung Cancer 32:227-36. 2001
  3. ncbi How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey
    Deborah A Marshall
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont, Canada
    Health Econ 18:1420-39. 2009
  4. ncbi Measuring patient preferences for colorectal cancer screening using a choice-format survey
    Deborah A Marshall
    McMaster University, Hamilton, ON, Canada
    Value Health 10:415-30. 2007
  5. ncbi The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada
    Deborah A Marshall
    Centre for Evaluation of Medicines, 105 Main Street East, Level P1, Hamilton, ON L8N 1G6, Canada
    Health Policy 84:1-13. 2007
  6. ncbi Economic decision analysis model of screening for lung cancer
    D Marshall
    McMaster University and Center for Evaluation of Medicines, McMaster University, 105 Main Street East, Level P1, ON, L8N 1G6, Hamilton, Canada
    Eur J Cancer 37:1759-67. 2001
  7. ncbi Cost-effectiveness of rhythm versus rate control in atrial fibrillation
    Deborah A Marshall
    Center for Evaluation of Medicine, McMaster University and St Joseph s Hospital, Hamilton, Ontario, Canada
    Ann Intern Med 141:653-61. 2004
  8. ncbi Review of economic evaluations of radiofrequency catheter ablation for cardiac arrhythmias
    Deborah A Marshall
    Department of Clinical Epidemiology and Biostatistics, McMaster University and Centre for Evaluation of Medicines, St Joseph s Hospital, Hamilton, Canada
    Can J Cardiol 19:1285-304. 2003
  9. ncbi Handling uncertainty in economic evaluations of patient level data: a review of the use of Bayesian methods to inform health technology assessments
    C Elizabeth McCarron
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Programs for Assessment of Technology in Health PATH Research Institute, Ontario, Canada
    Int J Technol Assess Health Care 25:546-54. 2009
  10. ncbi Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada
    Deborah A Marshall
    Global Health Economics and Outcomes Research, i3 Innovus, Burlington, Ontario, Canada
    Pharmacoeconomics 26:477-95. 2008

Detail Information

Publications15

  1. ncbi Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation
    Elisabeth Fenwick
    Public Health and Health Policy, University of Glasgow, Glasgow, UK
    BMC Health Serv Res 6:52. 2006
    ..The objective of the paper is to illustrate how to construct and interpret a CEAC...
  2. ncbi Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort
    D Marshall
    Bayer Diagnostics, Emeryville, CA, USA
    Lung Cancer 32:227-36. 2001
    ..Based on the assumptions embedded in this model, one-time screening of elderly high-risk patients for LC appears to be cost-effective...
  3. ncbi How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey
    Deborah A Marshall
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont, Canada
    Health Econ 18:1420-39. 2009
    ..We compared utility-based preferences for alternative CRC screening tests from a stated-preference discrete-choice survey of the general population and physicians in Canada and the United States...
  4. ncbi Measuring patient preferences for colorectal cancer screening using a choice-format survey
    Deborah A Marshall
    McMaster University, Hamilton, ON, Canada
    Value Health 10:415-30. 2007
    ..Our objective is to examine patient preferences for CRC screening modalities and uptake rates using utility-based methods...
  5. ncbi The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada
    Deborah A Marshall
    Centre for Evaluation of Medicines, 105 Main Street East, Level P1, Hamilton, ON L8N 1G6, Canada
    Health Policy 84:1-13. 2007
    ..Ontario required physicians to submit the clinical indications for their use on the prescription. British Columbia required physicians to seek and receive prior authorisation from the drug plan...
  6. ncbi Economic decision analysis model of screening for lung cancer
    D Marshall
    McMaster University and Center for Evaluation of Medicines, McMaster University, 105 Main Street East, Level P1, ON, L8N 1G6, Hamilton, Canada
    Eur J Cancer 37:1759-67. 2001
    ....
  7. ncbi Cost-effectiveness of rhythm versus rate control in atrial fibrillation
    Deborah A Marshall
    Center for Evaluation of Medicine, McMaster University and St Joseph s Hospital, Hamilton, Ontario, Canada
    Ann Intern Med 141:653-61. 2004
    ..Consequently, economic factors often play a role in guiding treatment selection...
  8. ncbi Review of economic evaluations of radiofrequency catheter ablation for cardiac arrhythmias
    Deborah A Marshall
    Department of Clinical Epidemiology and Biostatistics, McMaster University and Centre for Evaluation of Medicines, St Joseph s Hospital, Hamilton, Canada
    Can J Cardiol 19:1285-304. 2003
    ....
  9. ncbi Handling uncertainty in economic evaluations of patient level data: a review of the use of Bayesian methods to inform health technology assessments
    C Elizabeth McCarron
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Programs for Assessment of Technology in Health PATH Research Institute, Ontario, Canada
    Int J Technol Assess Health Care 25:546-54. 2009
    ..The results serve both as a reference and as a means by which to examine the appropriate application of Bayesian methods to inform decision making...
  10. ncbi Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada
    Deborah A Marshall
    Global Health Economics and Outcomes Research, i3 Innovus, Burlington, Ontario, Canada
    Pharmacoeconomics 26:477-95. 2008
    ..Both have been endorsed by the NPDUIS Steering Committee and the PMPRB for the standardization of BIA submissions...
  11. ncbi Resistance to antibiotics: administrative response to the challenge
    Deborah A Marshall
    Research and Development, Health Economics and Outcomes Research, Innovus Research Inc, Burlington, Ontario, Canada
    Manag Care Interface 17:20-9. 2004
    ....
  12. ncbi Design and analysis issues for economic analysis alongside clinical trials
    Deborah A Marshall
    Centre for Evaluation of Medicines, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    Med Care 47:S14-20. 2009
    ..Clinical trials can offer a valuable and efficient opportunity to collect the health resource use and outcomes data for economic evaluation. However, economic and clinical studies differ fundamentally in the question they seek to answer...
  13. ncbi Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee
    Deborah A Marshall
    Health Economics and Outcomes Research, i3 Innovus Research Inc, Burlington, Ontario, Canada
    Am J Manag Care 12:205-14. 2006
    ..To examine, in routine practice, the effectiveness and cost-effectiveness of oxycodone (OxyContin) compared with standard therapy for osteoarthritis pain...
  14. ncbi Assessing the impact of censoring of costs and effects on health-care decision-making: an example using the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
    Elisabeth Fenwick
    University of Glasgow, Glasgow, UK
    Value Health 11:365-75. 2008
    ....
  15. ncbi Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations
    Anna N A Tosteson
    Department of Medicine, Dartmouth Medical School, and The Dartmouth Institute of Health Policy and Clinical Practice ANAT, Lebanon, NH 03756, USA
    Am J Manag Care 14:605-15. 2008
    ..To evaluate the cost-effectiveness of osteoporosis treatments for women at high fracture risk and estimate the population-level impact of providing bisphosphonate therapy to all eligible high-risk US women...